Viewing Study NCT07076550


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2025-12-28 @ 5:08 AM
Study NCT ID: NCT07076550
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma
Sponsor: Alpha-9 Oncology USA Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module